InsidersTradesSigma
Track the 애드바이오텍 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 애드바이오텍 has published 7 public disclosures. Market capitalisation: €40.6bn. The latest transaction was filed on 18 June 2026 (Purchase). Among the most active insiders: 비케이파트너스투자조합1호. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
애드바이오텍 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于生物制药产品的开发。